Lead Product(s) : GLPG2451
Therapeutic Area : Genetic Disease
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 30, 2018
Lead Product(s) : GLPG2451
Therapeutic Area : Genetic Disease
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : GLPG2451
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Male Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 11, 2017
Lead Product(s) : GLPG2451
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : GLPG2451
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Pharmaceutical Research Associates | SGS Life Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Female Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 02, 2016
Lead Product(s) : GLPG2451
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Pharmaceutical Research Associates | SGS Life Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable